Wealth Enhancement Advisory Services LLC Purchases New Position in Maximus, Inc. $MMS

Key Points

• Wealth Enhancement Advisory Services LLC has acquired a new position in Maximus, Inc., purchasing 8,013 shares valued at approximately $577,000.
• Maximus reported earnings per share (EPS) of $2.16 for the last quarter, exceeding analyst expectations by $0.77 and showing a 2.5% year-over-year revenue increase.
• Institutional investors own 97.21% of Maximus's stock, with several firms significantly increasing their positions in the first quarter.

Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 8,013 shares of the health services provider's stock, valued at approximately $577,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its position in Maximus by 17,533.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after buying an additional 526 shares during the period. UMB Bank n.a. boosted its position in Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares during the period. GAMMA Investing LLC boosted its position in Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares during the period. NBC Securities Inc. boosted its position in Maximus by 114,900.0% during the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after buying an additional 1,149 shares during the period. Finally, Blue Trust Inc. boosted its position in Maximus by 32.8% during the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after buying an additional 303 shares during the period. 97.21% of the stock is owned by institutional investors.

Maximus Stock Down 0.0%

Shares of NYSE MMS opened at $91.25 on Friday. The company has a market capitalization of $5.14 billion, a P/E ratio of 16.80 and a beta of 0.57. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.73. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The company's 50 day moving average price is $85.06 and its 200-day moving average price is $75.38.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the company earned $1.74 EPS. Maximus's quarterly revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Insider Activity

In related news, insider Michelle F. Link sold 1,610 shares of the business's stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total transaction of $146,284.60. Following the transaction, the insider owned 13,508 shares in the company, valued at $1,227,336.88. The trade was a 10.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on MMS shares. Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 26th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Maximus in a research report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $90.00.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.